Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Ziracin

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2005
2005
Spontaneous hypospadias is seldom observed in rats in contrast to its occurrence in 1 out of 250 human births. Ziracin, an… Expand
  • table 1
  • table 2
  • table 3
  • figure 1
  • table 4
Is this relevant?
2002
2002
Five novel oligosaccharide antibiotics, Sch 58769 (1), Sch 58771 (2), Sch 58773 (3), Sch 58775 (4), and Sch 58777 (5), were… Expand
Is this relevant?
2001
2001
The pharmacokinetic properties of an everninomicin antibiotic (SCH27899; Ziracin) were studied with healthy Japanese male… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • table 2
Is this relevant?
2000
2000
The effectiveness of ziracin (SCH27899), a novel everninomicin, was at first investigated against lethal pneumonia caused by a… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
1999
1999
To combat the increasing rates of penicillin resistance among pneumococci and viridans group streptococci, new Gram-positive… Expand
Is this relevant?
1999
1999
The activities of Sch 27899 (Ziracin), erythromycin, and ofloxacin against 102 Legionella spp. isolates were measured by a… Expand
Is this relevant?
1999
1999
SCH27899 is an oligosaccharide, everninomicin antibiotic with activity primarily against Gram-positive pathogens. The activity of… Expand
Is this relevant?
1999
1999
Chemical modifications of eveminomicin antibiotics, particularly ziracin (1), were carried out to study the SARs as well as the… Expand
Is this relevant?
1999
1999
The powerful antibiotic everninomicin 13,384-1 (1, Ziracin) has been prepared for the first time through a total synthesis. The 1… Expand
Is this relevant?
1999
1999
The powerful antibiotic everninomicin 13,384-1 (1, Ziracin) has been prepared for the first time through a total synthesis. The 1… Expand
Is this relevant?